Mucopolysaccharidosis Type VI

  • Neulasta 2020 report

    Neulasta 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2019 report

    Naglazyme 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2018 report

    Naglazyme 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2017 report

    Naglazyme 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2016 report

    Naglazyme 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2015 report

    Naglazyme 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Naglazyme 2014 report

    Naglazyme 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 20 Pages The 5 Key Questions Addressed by this Report:...